16th Oct 2006 18:19
GlaxoSmithKline PLC16 October 2006 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in the interests of Directors, PersonsDischarging Managerial Responsibility or Connected Persons in the OrdinaryShares of GlaxoSmithKline plc. 28 September 2006 The Administrators of the SmithKline Beecham Employee Benefit Trust ("the Trust") notified the Company on 16 October 2006 that 16,122 Ordinary shares in the Company had been transferred on 28 September 2006 from the Trust to a participant in the GlaxoSmithKline Annual Investment Plan. The Trust also notified the Company on 16 October 2006 that 8,370 Ordinary shares in the Company had been purchased on 11 October 2006 on behalf of a participant in the GlaxoSmithKline Annual Investment Plan at a price of £14.59 per share. 11 October 2006 The Trust notified the Company on 16 October 2006 that 4,298 Ordinary shares in the Company had been transferred on 11 October 2006 to a participant in the GlaxoSmithKline Annual Investment Plan. The Trust also notified the Company on 16 October 2006 that 532 Ordinary shares in the Company had been purchased on 11 October 2006 on behalf of a participant in the Bonus Investment Plan at a price of £14.59 per share. The Trust is a discretionary fund of which all non US employees or formeremployees of GlaxoSmithKline plc and its subsidiaries are potentialbeneficiaries. One of the Company's directors, Mr J S Heslop is thereforeinterested in the shares held in the fund from time to time in the same way asother non US employees or former employees of GlaxoSmithKline plc and itssubsidiaries. This notification relates to a transaction notified in accordance withDisclosure Rule 3.1.4R(1)(b). S M Bicknell Company Secretary 16 October 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline